Fulcrum Therapeutics, Inc. (48) | License Agreements (2)

Recent Contracts

First Amendment to the Right of Reference and License Agreement, dated as of September 23, 2020, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2)... (Filed With SEC on November 10, 2020)
Right of Reference and License Agreement, dated as of February 8, 2019, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2) Limited, GlaxoSmithKline LLC and... (Filed With SEC on June 21, 2019)